Oral contraceptive use and impact of cumulative intake of estrogen and progestin on risk of ovarian cancer

M T Faber, A Jensen, K Frederiksen, Eva Glud, E Høgdall, C Høgdall, Jan Blaakær, S K Kjær

23 Citationer (Scopus)

Abstract

Oral contraceptive use decreases the risk of ovarian cancer, but no previous studies have assessed the impact of cumulative intake of estrogen and progestin on ovarian cancer risk.
OriginalsprogEngelsk
TidsskriftCancer causes & control
Sider (fra-til)2197-2206
ISSN0957-5243
DOI
StatusUdgivet - 29 sep. 2013

Fingeraftryk

Dyk ned i forskningsemnerne om 'Oral contraceptive use and impact of cumulative intake of estrogen and progestin on risk of ovarian cancer'. Sammen danner de et unikt fingeraftryk.

Citationsformater